Patent ID: 9333171
Filing Date: 2016-05-10
CPC Classification: A61K,A61P

Claim Text:
1. An intratympanic composition for use in the treatment of an otic disease or condition by administration on or near the round window membrane of the ear, the intratympanic composition comprising a micronized Central Nervous System (CNS) modulator, or pharmaceutically acceptable salt thereof; and an auris acceptable gel, wherein the auris acceptable gel has a viscosity between about 15,000 cP and about 1,000,000 cP, wherein the micronized Central Nervous System (CNS) modulator, or pharmaceutically acceptable salt thereof is not provided as polymer-containing particles, and is suspended in the auris acceptable gel; and wherein sustained release of the CNS modulator into the cochlea occurs for a period of at least 5 days after a single administration.